The US Food and Drug Administration granted 510(k) marketing clearances for various tests to aid the diagnosis and treatment of infectious diseases, among other products.

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Residual DNA Testing is vital in detecting trace DNA post-biological processes, crucial for safety across biotechnology, pharmaceuticals, and forensics. It ensures biopharmaceuticals like vaccines are ...

The Office of the Ombudsman has ordered the withdrawal of cases recently filed before the Sandiganbayan in connection with ...

Innovative graphene-silver metasurface biosensor combines nanotech and AI, providing real-time, label-free COVID-19 detection for future diagnostic applications.

The U.S. Food and Drug Administration has granted an emergency use authorization for a COVID-19 test from Alphabet Inc unit Verily Life Sciences.

Seven months after Brazil declared a state of emergency because of the new coronavirus pandemic, the country's Health Ministry has distributed less than a third of the 22.9 million available RT-PCR ...

Newly installed Ombudsman Jesus Crispin Remulla on Thursday said his immediate tasks would include a review of the ...

Anbio Biotechnology participated in the 50th World Small Animal Veterinary Association Congress (WSAVA 2025), an ...

Extended Partnership Agreement Will Expand Availability Across Europe of Gencurix’ In Vitro Diagnostic (IVD) Assays Using ...

Growing preference for rapid, portable DNA testing devices is reshaping diagnostic workflows, especially in remote and ...